跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,029 条关于
“microangiopathic hemolytic anemia”
全部
5,029
临床试验
3,940
药物
69
机构
17
资讯
1,003
8年前
EU Approves Sanofi's Cablivi as First Targeted Therapy for Rare Blood Clotting Disorder aTTP
2个月前
Eculizumab-Induced Acute Heart Failure Decompensation: A Novel Cardiotoxic Signal in Complement-Mediated TMA
2年前
FDA Approves Takeda's Adzynma as First Treatment for Ultra-Rare Blood Clotting Disorder cTTP
7个月前
Rituxan Receives Japanese Approval for Autoimmune Hemolytic Anemia Treatment
去年
New Clinical Trials Report Maps Global Landscape for Autoimmune Hemolytic Anemia Research
去年
FDA Grants Orphan Drug Designation to Sanofi's Rilzabrutinib for Autoimmune Hemolytic Anemia
8个月前
HUTCHMED's Sovleplenib Meets Primary Endpoint in Phase III Trial for Warm Autoimmune Hemolytic Anemia
去年
Low-Dose Rituximab Shows Transient Efficacy in Autoimmune Hemolytic Anemia
17天前
FDA Approves Johnson & Johnson's IMAAVY (nipocalimab-aahu) as First Therapy for Warm Autoimmune Hemolytic Anemia
去年
BCMA-Targeted Bispecific Antibody CM336 Shows Promise for Refractory Autoimmune Hemolytic Anemia in NEJM Study
第 1 页，共 101 页
上一页
下一页
